A study evaluating the feasibility of trial processes and delivery of an intervention for doctors and pharmacists working in older people’s medicine wards in hospitals in England, to facilitate the review and stopping of medicines no longer needed or where the risk of harm outweighs the benefit.

Two arm, open, purposive allocation feasibility study of a deprescribing behaviour change intervention for use by physicians and pharmacists with acute patients admitted to secondary care geriatric wards

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN11899506

Enrollment

400

Registered

2022-05-12

Start date

2022-06-29

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation of a deprescribing intervention for geriatricians and pharmacists in older adult medicine setting in acute hospitals in England Other

Interventions

Current interventions as of 22/05/2023: A theory and evidence-based intervention have been developed to address the barriers and enablers to geriatricians and pharmacists proactively deprescribing med

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinicians: 1. Geriatrician or pharmacists working in older adult medicine wards in hospitals in England Patients: 2. Patients receiving care from a participating clinician during the study window

Exclusion criteria

Exclusion criteria: Clinicians: 1. Less than 0.3 FTE ward time

Design outcomes

Primary

Measure	Time frame
Current primary outcome measures as of 22/05/2023: 1. Recruitment rate recorded as number of participants who consent to take part in the study by end of active study window. 2. Attrition rate recorded as the number of participants who consent to participate that remain in the study until the end of follow up. Previous primary outcome measures: 1. Recruitment rate recorded as number of participants who consent to take part in the study by end of active study window. 2. Attrition rate recorded as the number of participants who consent to participate that remain in the study until the end of follow up at 3 months.	—

Measure

Time frame

Current primary outcome measures as of 22/05/2023: 1. Recruitment rate recorded as number of participants who consent to take part in the study by end of active study window. 2. Attrition rate recorded as the number of participants who consent to participate that remain in the study until the end of follow up. Previous primary outcome measures: 1. Recruitment rate recorded as number of participants who consent to take part in the study by end of active study window. 2. Attrition rate recorded as the number of participants who consent to participate that remain in the study until the end of follow up at 3 months.

—

Secondary

Measure	Time frame
1. Hospital readmission rate measured using HES Admitted patient care data set at 3 months 2. Mortality rate measured using ONS death report data at 3 months 3. Quality of Life measured using EQ5D-5L and SF36 at baseline and at 3 months	—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 8, 2026